Science, politics and the pharmaceutical industry: controversy and bias in drug regulation
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | Undetermined |
| Veröffentlicht: |
London
UCL Press
1995
|
| Schlagworte: | |
| Beschreibung: | XI, 308 S. |
| ISBN: | 1857281993 1857282000 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV026142765 | ||
| 003 | DE-604 | ||
| 005 | 20110228 | ||
| 007 | t | ||
| 008 | 110326s1995 |||| 00||| und d | ||
| 020 | |a 1857281993 |9 1-85728-199-3 | ||
| 020 | |a 1857282000 |9 1-85728-200-0 | ||
| 035 | |a (DE-599)BVBBV026142765 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | |a und | ||
| 100 | 1 | |a Abraham, John |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Science, politics and the pharmaceutical industry |b controversy and bias in drug regulation |c John Abraham |
| 264 | 1 | |a London |b UCL Press |c 1995 | |
| 300 | |a XI, 308 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 0 | 7 | |a Arzneimittel |0 (DE-588)4003115-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Gesundheitspolitik |0 (DE-588)4113743-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Zulassung |0 (DE-588)4127410-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelsicherheit |0 (DE-588)4143182-0 |2 gnd |9 rswk-swf |
| 651 | 7 | |a USA |0 (DE-588)4078704-7 |2 gnd |9 rswk-swf | |
| 651 | 7 | |a Großbritannien |0 (DE-588)4022153-2 |2 gnd |9 rswk-swf | |
| 655 | 7 | |8 1\p |0 (DE-588)4522595-3 |a Fallstudiensammlung |2 gnd-content | |
| 689 | 0 | 0 | |a USA |0 (DE-588)4078704-7 |D g |
| 689 | 0 | 1 | |a Arzneimittelsicherheit |0 (DE-588)4143182-0 |D s |
| 689 | 0 | 2 | |a Gesundheitspolitik |0 (DE-588)4113743-7 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Großbritannien |0 (DE-588)4022153-2 |D g |
| 689 | 1 | 1 | |a Arzneimittelsicherheit |0 (DE-588)4143182-0 |D s |
| 689 | 1 | 2 | |a Gesundheitspolitik |0 (DE-588)4113743-7 |D s |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a USA |0 (DE-588)4078704-7 |D g |
| 689 | 2 | 1 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
| 689 | 2 | 2 | |a Zulassung |0 (DE-588)4127410-6 |D s |
| 689 | 2 | |5 DE-604 | |
| 689 | 3 | 0 | |a Großbritannien |0 (DE-588)4022153-2 |D g |
| 689 | 3 | 1 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
| 689 | 3 | 2 | |a Zulassung |0 (DE-588)4127410-6 |D s |
| 689 | 3 | |5 DE-604 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-021731259 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
Datensatz im Suchindex
| _version_ | 1804144590016479232 |
|---|---|
| any_adam_object | |
| author | Abraham, John |
| author_facet | Abraham, John |
| author_role | aut |
| author_sort | Abraham, John |
| author_variant | j a ja |
| building | Verbundindex |
| bvnumber | BV026142765 |
| ctrlnum | (DE-599)BVBBV026142765 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01983nam a2200529 c 4500</leader><controlfield tag="001">BV026142765</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20110228 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">110326s1995 |||| 00||| und d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1857281993</subfield><subfield code="9">1-85728-199-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1857282000</subfield><subfield code="9">1-85728-200-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV026142765</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">und</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Abraham, John</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Science, politics and the pharmaceutical industry</subfield><subfield code="b">controversy and bias in drug regulation</subfield><subfield code="c">John Abraham</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London</subfield><subfield code="b">UCL Press</subfield><subfield code="c">1995</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XI, 308 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gesundheitspolitik</subfield><subfield code="0">(DE-588)4113743-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Zulassung</subfield><subfield code="0">(DE-588)4127410-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelsicherheit</subfield><subfield code="0">(DE-588)4143182-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">Großbritannien</subfield><subfield code="0">(DE-588)4022153-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">1\p</subfield><subfield code="0">(DE-588)4522595-3</subfield><subfield code="a">Fallstudiensammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimittelsicherheit</subfield><subfield code="0">(DE-588)4143182-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Gesundheitspolitik</subfield><subfield code="0">(DE-588)4113743-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Großbritannien</subfield><subfield code="0">(DE-588)4022153-2</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Arzneimittelsicherheit</subfield><subfield code="0">(DE-588)4143182-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Gesundheitspolitik</subfield><subfield code="0">(DE-588)4113743-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="2"><subfield code="a">Zulassung</subfield><subfield code="0">(DE-588)4127410-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">Großbritannien</subfield><subfield code="0">(DE-588)4022153-2</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="3" ind2="1"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="2"><subfield code="a">Zulassung</subfield><subfield code="0">(DE-588)4127410-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-021731259</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield></record></collection> |
| genre | 1\p (DE-588)4522595-3 Fallstudiensammlung gnd-content |
| genre_facet | Fallstudiensammlung |
| geographic | USA (DE-588)4078704-7 gnd Großbritannien (DE-588)4022153-2 gnd |
| geographic_facet | USA Großbritannien |
| id | DE-604.BV026142765 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-09T23:05:58Z |
| institution | BVB |
| isbn | 1857281993 1857282000 |
| language | Undetermined |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-021731259 |
| open_access_boolean | |
| physical | XI, 308 S. |
| publishDate | 1995 |
| publishDateSearch | 1995 |
| publishDateSort | 1995 |
| publisher | UCL Press |
| record_format | marc |
| spelling | Abraham, John Verfasser aut Science, politics and the pharmaceutical industry controversy and bias in drug regulation John Abraham London UCL Press 1995 XI, 308 S. txt rdacontent n rdamedia nc rdacarrier Arzneimittel (DE-588)4003115-9 gnd rswk-swf Gesundheitspolitik (DE-588)4113743-7 gnd rswk-swf Zulassung (DE-588)4127410-6 gnd rswk-swf Arzneimittelsicherheit (DE-588)4143182-0 gnd rswk-swf USA (DE-588)4078704-7 gnd rswk-swf Großbritannien (DE-588)4022153-2 gnd rswk-swf 1\p (DE-588)4522595-3 Fallstudiensammlung gnd-content USA (DE-588)4078704-7 g Arzneimittelsicherheit (DE-588)4143182-0 s Gesundheitspolitik (DE-588)4113743-7 s DE-604 Großbritannien (DE-588)4022153-2 g Arzneimittel (DE-588)4003115-9 s Zulassung (DE-588)4127410-6 s 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Abraham, John Science, politics and the pharmaceutical industry controversy and bias in drug regulation Arzneimittel (DE-588)4003115-9 gnd Gesundheitspolitik (DE-588)4113743-7 gnd Zulassung (DE-588)4127410-6 gnd Arzneimittelsicherheit (DE-588)4143182-0 gnd |
| subject_GND | (DE-588)4003115-9 (DE-588)4113743-7 (DE-588)4127410-6 (DE-588)4143182-0 (DE-588)4078704-7 (DE-588)4022153-2 (DE-588)4522595-3 |
| title | Science, politics and the pharmaceutical industry controversy and bias in drug regulation |
| title_auth | Science, politics and the pharmaceutical industry controversy and bias in drug regulation |
| title_exact_search | Science, politics and the pharmaceutical industry controversy and bias in drug regulation |
| title_full | Science, politics and the pharmaceutical industry controversy and bias in drug regulation John Abraham |
| title_fullStr | Science, politics and the pharmaceutical industry controversy and bias in drug regulation John Abraham |
| title_full_unstemmed | Science, politics and the pharmaceutical industry controversy and bias in drug regulation John Abraham |
| title_short | Science, politics and the pharmaceutical industry |
| title_sort | science politics and the pharmaceutical industry controversy and bias in drug regulation |
| title_sub | controversy and bias in drug regulation |
| topic | Arzneimittel (DE-588)4003115-9 gnd Gesundheitspolitik (DE-588)4113743-7 gnd Zulassung (DE-588)4127410-6 gnd Arzneimittelsicherheit (DE-588)4143182-0 gnd |
| topic_facet | Arzneimittel Gesundheitspolitik Zulassung Arzneimittelsicherheit USA Großbritannien Fallstudiensammlung |
| work_keys_str_mv | AT abrahamjohn sciencepoliticsandthepharmaceuticalindustrycontroversyandbiasindrugregulation |